DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,225.00
+5.00 (0.23%)
Sep 14, 2026, 1:51 PM KST

DK Life Science Revenue

DK Life Science had revenue of 24.26B KRW in the quarter ending June 30, 2026, a decrease of -30.47%. This brings the company's revenue in the last twelve months to 117.75B, down -12.22% year-over-year. In the year 2025, DK Life Science had annual revenue of 130.34B, down -1.12%.

Revenue (ttm)
117.75B
Revenue Growth
-12.22%
P/S Ratio
0.60
Revenue / Employee
1.18B
Employees
100
Market Cap
71.00B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025130.34B-1.47B-1.12%
Dec 31, 2024131.82B11.65B9.70%
Dec 31, 2023120.16B12.93B12.05%
Dec 31, 2022107.23B4.57B4.45%
Dec 31, 2021102.67B-6.91B-6.31%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Samsung Biologics5.12T
Celltrion4.90T
Samsung Epis Holdings1.51T
Ildong Holdings607.65B
ALTEOGEN254.01B
CKD Bio159.93B
DRTECH126.23B
Ray Co., Ltd.119.17B
Revenue Rankings